Trivant Custom Portfolio Group’s Thermo Fisher Scientific TMO Stock Holding History

Trivant Custom Portfolio Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,305	Closed	-$2.14M	–	198
2025 Q1	$2.14M	Buy	4,305 +98	+2%	+$53.1K	1.23%	24
2024 Q4	$2.19M	Sell	4,207 -191	-4%	-$105K	1.28%	27
2024 Q3	$2.72M	Buy	4,398 +19	+0.4%	+$11.2K	1.57%	25
2024 Q2	$2.42M	Sell	4,379 -87	-2%	-$49.8K	1.49%	29
2024 Q1	$2.6M	Buy	4,466 +233	+6%	+$131K	1.65%	31
2023 Q4	$2.25M	Sell	4,233 -413	-9%	-$200K	1.5%	34
2023 Q3	$2.35M	Sell	4,646 -23	-0.5%	-$12.3K	1.73%	26
2023 Q2	$2.44M	Buy	4,669 +4,009	+607%	+$2.16M	1.72%	28
2023 Q1	$380K	Buy	+660	New	+$372K	0.27%	45

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Trivant Custom Portfolio Group's TMO Position: Q2 2025 in Review

Trivant Custom Portfolio Group sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 4,305 shares — an estimated $2.14M sold.

Trivant Custom Portfolio Group first reported a position in TMO in Q1 2023 and held it in 9 quarters. The position peaked at $2.72M in Q3 2024. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Trivant Custom Portfolio Group reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Trivant Custom Portfolio Group sold 4,305 Thermo Fisher Scientific shares in Q2 2025, an estimated $2.14M.
Trivant Custom Portfolio Group first reported a position in Thermo Fisher Scientific in Q1 2023 and held it in 9 quarters.
Trivant Custom Portfolio Group's Thermo Fisher Scientific position peaked at $2.72M in Q3 2024.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Trivant Custom Portfolio Group's 13F filing for Q2 2025, filed 12 Aug 2025.